tissue regeneration
novel tissue
biomaterial scaffold augmentation agent
de-novo tissue
temporary tissue fillers
long-term tissue augmentation effect
risks
permanent bulking agent
CellFoam
efficacy
materials
stress urinary incontinence
revolutionary solution
innovation project
dogs Injectable bulking agents
urethral remodelling
foreign body granulomas
post-project exploitation
present feasibility study
commercialization
cells
immunological adverse events
subsequent phases
bovine crosslinked collagen product
Contigen
overarching objective
biocompatibility
usability
reproducible response
safety
place
planned industrialization
Lack
durability
results
issues
PMSI
production
adoption
application
effectivity
months